Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2021 May 26;60(4):103160. doi: 10.1016/j.transci.2021.103160

Use of face mask by blood donors during the COVID-19 pandemic: Impact on donor hemoglobin concentration: A bane or a boon

Rasika Setia a,*, Mitu Dogra a, Anil Handoo b, Ramesh Yadav a, Gokhula Prasath Thangavel a, Amena Ebadur Rahman a
PMCID: PMC8152240  PMID: 34217601

Abstract

Background

COVID-19 virus has caused the world’s deadliest pandemic. Early April 2020, the Delhi Government made it compulsory for people to wear face masks while going outdoors to curb disease spread. Prolonged use of surgical masks during the pandemic has been reported to cause many adverse effects. Intermittent hypoxia has been shown to activate erythropoietin (EPO leading to increased hemoglobin mass.

Aim

To analyze whether face mask induced intermittent hypoxia has any effect on the hemoglobin levels of healthy blood donors.

Materials and methods

We retrospectively analyzed donor data from 1st July 2019-31st December 2020 for hemoglobin distribution across hemoglobin ranges and donor deferral on basis of hemoglobin. Study population was divided into two cohorts Group 1- (1st July 2019-31 st March 2020): before implementation of mandatory face masks Group 2- (1st April 2020-31 st December 2020): after implementation of mandatory face masks

Results

Mean Hb of blood donors in Group 2 (15.01 ± 1.1 g/dl) was higher than Group1 (14.49 ± 1.15 g/dl), (p < 0.0001). 47.1 % group2 donors had Hb of 16.1−18 g/dl compared to group1 (38.4 %). 52.9 % group 2 donors had Hb between 12.5−15 g/dl compared to 61.6 % Group 1 (p < 0.05). Deferral due to anemia was lesser in group 2 compared to group 1 (p < 0.00001). Group 2 had significantly higher deferral due to high Hb (>18 gm/dl) was than Group 1 (p = 0.0039).

Conclusion

This study including 19504 blood donors spanning over one and a half year shows that prolonged use of face mask by blood donors may lead to intermittent hypoxia and consequent increase in hemoglobin mass.

Keywords: Face mask, Prolonged use, Donor hemoglobin, Erythropoietin, Intermittent hypoxia, COVID-19

1. Introduction

COVID-19 virus that has led to one of the world’s deadliest pandemic is thought to spread from person to person, mainly through respiratory droplets produced when an infected person coughs or sneezes [1]. Along with the well-accepted measures of physical distancing and frequent hand washing, the use of face masks or face covering, emerged as a third pillar in community action as a doable and low-cost measure to contain the spread of the disease. In early April 2020, the Delhi Government like many other states across India made it compulsory for people to wear face masks while going outdoors to curb the disease spread [2]. Various studies have emerged ever since analysing the benefits and risks of face masks during the COVID-19 crisis [3].

With the continuous use of face mask as personal protective equipment, infectious disease studies have reported a historic drop in cases of influenza with sustainably low inter-seasonal levels across the world during the COVID-19 crisis [4,5]. Face mask, are now well established personal protective equipment against respiratory droplets, however prolonged use of surgical masks and N95 by healthcare professionals during COVID-19 pandemic have been reported to cause many adverse effects such as headaches, rash, acne, skin breakdown, breathing difficulty and impaired cognition in the majority of those surveyed [6,7]. Beder A et al. [8] in their study have reported decrease in the oxygen saturation of arterial pulsations (SpO2) and a slight increase in pulse rates compared to preoperative values in all surgeon groups after performing operations, possibly correlated to use of facial mask and also operational stress. Surgical mask usage has also been reported to result in hypo-oxygenemia and hypercapnia which reduce working efficiency [9]. As recent history has not experienced a time that has mandated the use of face coverings and use of face masks in public spaces, the majority of research exploring the impact of masks on human physiology has been conducted on surgical masks [8] and N95 respirators [9] but none of them consider the simple cloth mask.

Under normal conditions, erythropoietin (EPO) production is mediated by decreased oxygen saturation of hemoglobin (Hb), that is, hypoxemia. The ambient hypoxia triggers a number of physiologic responses including hyperventilation, increased resting heart rate and stimulation of erythrocyte production with the goal of maintaining the oxygen content of arterial blood at or above sea level values [[10], [11], [12]].

Wearing Face masks over a period of 8–10 h per day continuously may create a condition of intermittent hypoxia that may lead to change in Hb levels in otherwise healthy blood donors.

2. Aims and objectives

The aim of this study is to analyse if face mask induced intermittent hypoxia has any effect on the hemoglobin levels of healthy blood donors. Analysing the hemoglobin distribution across hemoglobin ranges and donor deferral on basis of hemoglobin in the period before and after regulatory requirement mandating use of face, to quantify this expected variation. There are no studies in literature so far which have studied effect of face mask in blood donors during this COVID-19 crisis.

3. Materials and methods

This is a retrospective single centre-based cross-sectional study analysing a changing trend in average hemoglobin range and pre-donation deferral record of blood and platelet apheresis donors on basis of hemoglobin level at our blood bank attached to a large super speciality hospital in New Delhi, India. Data was retrieved from the blood bank information system and manual records for a period of one and half years, from 1st July 2019 to 31st December 2020. Analysis of donor deferral reasons was performed in relation the donor questionnaire and hemoglobin (Hb) estimation. Blood donors acceptance or deferral was based on for donor selection as per Drugs and Cosmetics Drugs and Cosmetics Act (the rules thereunder) [13] and supplemented by the National Blood Transfusion Council (NBTC) and National AIDS Control Organisation (NACO) guidelines, including their amendments [14]. Hb cut-off of 12.5–18 g/dl detected by quantitative method of hemoglobin estimation on a portable hemoglobin analyser (Hemocue Hb 301) was followed for donations for donors were fulfilling all other selection criteria.

3.1. Study design and setting

Study population was divided into two cohorts based on compulsory enforcement for people to wear face masks while going outdoors to curb the disease spread by the Delhi Government.

Group 1- (1st July 2019-31st March 2020): before implementation of mandatory face masks

Group 2- (1st April 2020-31st December 2020): after implementation of mandatory face masks

3.2. Ethical approval

The institutional ethical clearance was obtained from the Institutional ethics committee. As a blood donation screening and registration protocol of the blood bank all blood donors give an informed consent prior to blood donation for any additional testing on the blood collected and its subsequent use for study/research purposes and the same are in place. In view of retrospective study design and no risk of disclosure of donor identity involved in this study, the requirement to obtain the blood donors’ consent to review the donor records was waived off by the institutional ethical committee. Confidentiality of the data was maintained, and the study procedures were performed in compliance with the 1964 Helsinki declaration and its later amendment.

3.3. Inclusion and exclusion criteria

Voluntary, non-remunerated, whole blood donors and platelet apheresis donors recruited during this time period and deferred either due to low Hb (<12.5 gm/dl) or high Hb (>18 gm/dl) were included however, donors deferred because of high hemoglobin due to primary polycythaemia & established causes of secondary polycythaemia e.g.: giving history of chronic smoking) or with permanent address of high altitude areas or donors with history of renal disease or other known cases of polycythaemia were excluded from the study.

3.4. Statistical analysis

Descriptive statistical analysis, like percentage was used. Chi-square χ2 test with Yate’s correction was used to assess the categorical variables. P-value <0.05 was considered as statistically significant.

4. Results

A total of 19,504 voluntary, non-remunerated, whole blood donors and platelet apheresis donors including 20.5 % (n = 3998) of family/friend donors were included in the study. The mean age was 34.5 ± 7.63 years (18–65). The ratio of male to female donors screened was 17:1 (Table 1 ).

Table 1.

Donor profile with percentage of selected and deferred blood and platelet donors.

Group 1
Group 2
N % N %
Total Screened 10873 8631
Gender
 Male 10259 94.4 8069 93.5
 Female 614 5.6 562 6.5
Occupation
 Professional 3175 29.2 2931 34.0
 Government service 1935 17.8 2512 29.1
 Semi-professional /self employed 3382 31.1 1695 19.6
 Student 1294 11.9 766 8.9
 Others 1087 10.0 727 8.4
Total Donated 9296 7621
Donor Type
 Voluntary 7460 80.2 5989 78.6
 Voluntary Family/Friend donors 1836 19.8 1632 21.4
 First Time Donors 3319 35.7 2890 37.9
 Repeat Donors 5977 64.3 4731 62.1
Gender
 Male 9060 97.5 7430 97.5
 Female 236 2.5 191 2.5
Total Deferral 1577 14.5 1010 11.7
 Male 1199 11.03 839 9.72
 Female 378 3.48 171 1.98

4.1. Hemoglobin based distribution of selected donors according to hemoglobin range (Table 2)

Table 2.

Hemoglobin based distribution of selected donors according to hemoglobin range.

Hb range Group1
Group 2
P- value
(g/dl) N %* N % *
Mean (±SD) Hb 14.49 (1.15) 15.01(1.1) P < 0.0001
12.5−13 917 9.9 576 7.6 0.03
13.1−14 2012 21.7 1372 18.0 0.0199
14.1−15 2793 30 2080 27.3 0.006
15.1−16 2392 25.7 2234 29.3 0.0003
16.1−17 1161 12.5 1310 17.2 0.0016
17.1−18 21 0.2 49 0.6 0.0032
Total 9296 100 7621 100
*

Percentage of the total in the respective Hb category.

4.1.1. Group 1 (1st July 2019 to 31st March 2020)

10873 donors were screened during this period, of which 94.4 % (n = 10259) were males and 5.6 % (n = 614) were female donors. Following the pre-donation screening process, 9296 blood donors were selected and 1577 donors were deferred, resulting in a mean deferral rate of 14.5 %. 80.2 %(n = 7420) of the 9296 selected donors were voluntary donors, 19.8 % (n = 1836) were family/friend donors and 64.3 % (n = 5977) of the accepted donors were repeat blood donors. The accepted blood donors had a mean Hb of 14.49 ± 1.15 g/dl. 30 % of the selected blood donors fell in 14.1−15 gm/dl range, followed by 25.7 % in 15.1−16 g/dl range and 21.7 % were in the 13.1−14 g/dl bracket. 9% had an Hb between 12.−13 g/dl. The higher Hb ranges of 16.1−17 g/dl and 17.1−18 g/dl had 12.5 % and 0.2 % respectively, in the Group 1.

4.1.2. Group 2 (1st April 2020 to 31st December 2020)

A total of 8631 donors were screened during this period, of which 93.5 % (n = 8069) were male, and 6.5 % (n = 562) were female donors. 7621 blood donors were accepted after the pre-donation screening process. 78.2 %(n = 5989) of the 7621 selected donors were voluntary donors, 21.4 % (n = 1632) were family/friend donors and 62.1 % (n = 4731) of the accepted donors were repeat blood donors. The accepted blood donors had a mean Hb of 15.01 ± 1.1 g/dl. 29.3 % of the blood donors fell in 15.1−16 gm/dl range, followed by 27.3 % in 14.1−15 g/dl range and 18 % in the 13.1−14 g/dl bracket. 7.6 % of the total donors had an Hb between 12.−13 g/dl. The higher Hb ranges of 16.1−17 g/dl and 17.1−18 g/dl had 17.5 % and 0.6 % respectively.

4.2. The characteristics of deferred donors on basis of hemoglobin (Table 3 & Fig. 1)

Table 3.

Characteristics of deferred donors on basis of hemoglobin.

Group 1
Group 2
P value
N % N %
Total Deferred 1577 1010
Low Hb (<12.5 g/dl) 429 27.20 226 22.38 <0.00001
Male 162 37.76 104 46.02 0.093
Female 267 62.24 122 53.98 < 0.00001
High Hb (>18 g/dl)-(Included in the study) 62 3.93 80 7.92 0.0039
Male 62 100 80 100
Female 0 0 0 0

Fig. 1.

Fig. 1

Hemoglobin based distribution of selected donors according to hemoglobin range.

4.2.1. Group 1 (1st July 2019 to 31st March 2020)

Of the total deferrals 27.2 % (n = 429) deferrals were due to low Hb and 3.93 % (n = 62) due to high hemoglobin (due to unknown cause) against Hb cut-off of 12.5–18 g/dl. The proportion of low Hb deferral was high in female donors 62.24 % (267/429) as compared to male donors 37.76 % (162/429), while 100 % (n = 62) of high Hb deferrals were male donors. High Hb levels ranged between 18.1 and 20.0 g/dl .

4.2.2. Group 2 (1st April 2020 to 31st December 2020)

Amongst the total deferral of 1010 donors, 22.38 % (n = 226) deferrals were due to low Hb and 0.92 % (n = 80) were deferred due high hemoglobin (due to unknown cause). High Hb levels ranged between 18.1 and 21.1 g/dl. Female deferral due to low Hb was higher than male deferrals.

The percentage of donor deferrals in our study due to low Hb was lesser in group 2 (22.38 %) as compared to group 1 (27.20 %) and this difference was statistically significant (p < 0.00001). This drop in female donors with anemia in group 2 (53.98 %) as compared to group 1 (62.24 %) was also statistically significant (p < 0.00001).

A significant rise in donor deferral due to high Hb is seen in group 2 as compared to group 1 (p = 0.093).

5. Discussion

The use of masks has become the new normal for humankind after the COVID-19 outbreak. It will not be incorrect to say that -face masks have become a new iconic symbol of 2020. When history looks back on the pandemic of 2020, those white or baby blue rectangles that hide the mouth and nose, turning everyone into a muzzled pelican, will be what they will see [15].

In this single centre, retrospective, cohort study, hemoglobin concentrations showed a significant variation in the group of donors after wearing face masks was mandated by authorities as compared to donors in the period without mandatory use of face masks. To our best knowledge, this is the first study, studying the effect of hemoglobin profile of healthy blood donors, after prolonged use of face masks by blood donors.

In our study, mean Hb of accepted blood donors in Group2 (15.01 ± 1.1 g/dl) was also higher than Group 1 (14.49 ± 1.15 g/dl) and the difference was statistically significant (p < 0.0001). Group 2 showed an overall trend of donors having higher hemoglobin compared to group 1. 47.1 % of group 2 donors had Hb of 16.1−18 g/dl compared to 38.4 % in group 1. Similarly there was overall decrease in percentage of donors in lower Hb ranges in group 2. Lesser number of group 2 donors (52.9 %) had an Hb between 12.5−15 g/dl compared to 61.6 % of Group 1 donors. This trend of an overall increased percentage of donors in higher hemoglobin ranges and a decrease in donors in lower Hb ranges was statistically significant (across all Hb ranges). Two groups were comparable in terms of donor demographics. The percentages of voluntary blood donors in both the groups are similar. Same is the case with percentage of first time and repeat blood donors and therefore these would not have impacted the hemoglobin distribution in the two groups. The occupation profile of donors engaged in outdoor activities is similar in both the groups studied. 91.6 % of the donors of group 2 were involved professions that would need outdoor movement, requiring mandatory use of face masks while performing professional activities. These observations are further substantiated by a statistically significant decrease in donor deferral in group 2 as compared to group 1 due to low Hb especially in female donors. In addition deferral in group2 donors due to high Hb (>18 gm/dl) was significantly higher in group 2 than Group 1, again indicating a shift to higher Hb concentration in the blood donors.

5.1. Possible mechanisms

The potential mechanism of increase in hemoglobin concentrations in blood donors in Group2 can possibly be attributed to the prolonged use of face masks, that can be N95 mask, surgical mask or simply a cloth mask by these blood donors leading to intermittent hypoxia that may have led to EPO production in order to restore oxygen supply to the tissues, resulting in increase in hemoglobin mass in otherwise healthy blood donors. Respiratory rate, oxygen saturation and CO2 levels have been shown to change significantly while wearing N95/FFP2 masks [16,17]. Various studies and trials have being conducted to evaluate the physiological impact of masks in medical staff. An observational study of 52 surgeons wearing surgical masks revealed a decrease in arterial O2 saturation from approximately 98 % before surgery to 96 % after surgery, which ranged from 1 to 4 h in length [8]. Studies have also shown that a few minutes of exposure to hypoxia stabilizes hypoxia inducible factor-1α, which activates erythropoietin (EPO) gene transcription and EPO production, in order to restore oxygen supply to the tissues [16,18]. Burtscher et al. [19], in their study, have reported that fifteen sessions of intermittent hypoxia, by breathing hypoxic air for 3–5 min interspersed with 3 min of breathing normoxic air over a period of 3 weeks led to increased hemoglobin mass and exercise tolerance in a group of healthy active individuals at risk for chronic obstructive pulmonary disease (COPD) and patients with mild COPD. During the period of lockdown and immediately after the lockdown when restricted movements were observed, the Air Quality of Delhi improved significantly and has the potential to affect the haematological parameters. However, an epidemiological study on “Effect of Air Pollution on Human Health (Adults)” in Delhi by Central Pollution Control Board Ministry Of Environment & Forests shows a small, but consistent rise in hemoglobin and RBC level among the residents of Delhi attributed to chronic air pollution induced oxidative stress negating the possibility of good air quality in increasing haemoglobin level [20].

In this study, we also found that an overall shift to higher Hb in the Group 2 donors with a significant number of donors reporting with higher Hb and a drop in donor deferral due to low Hb as compared to group 1, following prolonged usage of facemask.

5.2. Study limitations

Being retrospective and observational in nature, a potential limitation of the present study is that a complete blood count, arterial oxygen saturation and serum EPO level were not performed, which would help elicit a rise in EPO levels or erythrocytosis in these donors. Correlation with pre-COVID-19 Hb of donors with current Hb following exposure to intermittent hypoxia and duration for which the donors wore face masks could also not be elicited. However majority of the donors were from the working category which would involve moving outdoors and therefore use of face masks for longer periods.

Nonetheless, the present findings represent an important first step to future studies to investigate the effect of prolonged use of face masks causing intermittent hypoxia in blood donors and its possible consequences on the Hb mass of blood donors.

6. Conclusion

In conclusion, this study with 19,504 blood donors spanning over one and a half year, is adequate enough for the technical hypothesis, that prolonged use of face mask by blood donors may lead to intermittent hypoxia and consequent increase in Hb mass but insufficient for evaluation of multifactorial effects.

CRediT authorship contribution statement

Conceptualization: RS, MD, RY. Methodology: RS, MD. Statistical analyses and interpretation: GPT, RS, MD. Resources: RY, GPT, AER. Writing- Original Draft: RS, MD. Writing- Review & Editing: RS, AH.

Financial and Funding

The authors have no financial relationships relevant to this article to disclose. This study did not receive any specific grant from funding agencies in public, commercial, or not-for-profit sectors.

Declaration of Competing Interest

All authors declare that they do not have any conflict of interest that could inappropriately influence the present study.

Acknowledgement

There are no acknowledgements.

References


Articles from Transfusion and Apheresis Science are provided here courtesy of Elsevier

RESOURCES